大连医科大学学报
大連醫科大學學報
대련의과대학학보
Journal of Dalian Medical University
2015年
5期
447-450
,共4页
裸鼠%结直肠癌%半脾模型%药物筛选模型
裸鼠%結直腸癌%半脾模型%藥物篩選模型
라서%결직장암%반비모형%약물사선모형
nude mice%colon cancer%hemispleen model%drug screening model
目的:建立稳定的裸鼠结直肠癌肝转移半脾模型。方法利用裸鼠脾脏的特殊解剖,建成半脾模型后,将人HT29结直肠癌细胞接种于近端半脾被膜下,远端半脾埋入皮下备治疗所需。采用不同浓度的肿瘤细胞(5×105/100μL、1×106/100μL及5×106/100μL)或不同浓度的环磷酰胺( L-CTX和H-CTX),共分6组观察制模30天后的肝转移评分、淋巴结转移及血性腹水情况。结果人HT29结直肠癌细胞建立的肝转移半脾模型成瘤率和减瘤率皆为100%。 L-CTX治疗组和H-CTX治疗组观察结果,发现随结直肠癌细胞浓度梯度的增高肝转移评分也增高,其不同浓度梯度间的差异有显著性意义(两组均为P<0.05)。 L-CTX治疗组淋巴结转移和血性腹水明显少于H-CTX治疗组,其差异也有显著性意义(P<0.05)。人HT29结直肠癌细胞浓度梯度为1×106/100μL制模组,显示其模型稳定性和抗肿瘤药物的敏感性最好。结论裸鼠结直肠癌肝转移半脾模型为结直肠癌肝转移的生物学机制和抗转移治疗提供了较为理想的实验模型。肝转移半脾模型为抗肿瘤药物体外筛选模型方法,其模型的建立能应用于抗肿瘤药物的筛选。
目的:建立穩定的裸鼠結直腸癌肝轉移半脾模型。方法利用裸鼠脾髒的特殊解剖,建成半脾模型後,將人HT29結直腸癌細胞接種于近耑半脾被膜下,遠耑半脾埋入皮下備治療所需。採用不同濃度的腫瘤細胞(5×105/100μL、1×106/100μL及5×106/100μL)或不同濃度的環燐酰胺( L-CTX和H-CTX),共分6組觀察製模30天後的肝轉移評分、淋巴結轉移及血性腹水情況。結果人HT29結直腸癌細胞建立的肝轉移半脾模型成瘤率和減瘤率皆為100%。 L-CTX治療組和H-CTX治療組觀察結果,髮現隨結直腸癌細胞濃度梯度的增高肝轉移評分也增高,其不同濃度梯度間的差異有顯著性意義(兩組均為P<0.05)。 L-CTX治療組淋巴結轉移和血性腹水明顯少于H-CTX治療組,其差異也有顯著性意義(P<0.05)。人HT29結直腸癌細胞濃度梯度為1×106/100μL製模組,顯示其模型穩定性和抗腫瘤藥物的敏感性最好。結論裸鼠結直腸癌肝轉移半脾模型為結直腸癌肝轉移的生物學機製和抗轉移治療提供瞭較為理想的實驗模型。肝轉移半脾模型為抗腫瘤藥物體外篩選模型方法,其模型的建立能應用于抗腫瘤藥物的篩選。
목적:건립은정적라서결직장암간전이반비모형。방법이용라서비장적특수해부,건성반비모형후,장인HT29결직장암세포접충우근단반비피막하,원단반비매입피하비치료소수。채용불동농도적종류세포(5×105/100μL、1×106/100μL급5×106/100μL)혹불동농도적배린선알( L-CTX화H-CTX),공분6조관찰제모30천후적간전이평분、림파결전이급혈성복수정황。결과인HT29결직장암세포건립적간전이반비모형성류솔화감류솔개위100%。 L-CTX치료조화H-CTX치료조관찰결과,발현수결직장암세포농도제도적증고간전이평분야증고,기불동농도제도간적차이유현저성의의(량조균위P<0.05)。 L-CTX치료조림파결전이화혈성복수명현소우H-CTX치료조,기차이야유현저성의의(P<0.05)。인HT29결직장암세포농도제도위1×106/100μL제모조,현시기모형은정성화항종류약물적민감성최호。결론라서결직장암간전이반비모형위결직장암간전이적생물학궤제화항전이치료제공료교위이상적실험모형。간전이반비모형위항종류약물체외사선모형방법,기모형적건립능응용우항종류약물적사선。
Objective To establish a feasible and stable hepatic metastases of colon cancer model with nude mice hemis-pleen method.Methods The spleen was divided, creating two hemispleens with their own vascular pedicle.HT29 human colon cancer cells were injected beneath the inferior hemispleen capsules of nude mice, establishing models of liver metas-tases in nude mice.Then removing the inferior hemispleen, the superior hemispleen was placed in the left s.c.pocket for treatmentinjection.The liver metastasis score, lymph node metastasis, and bloody ascites were studied after different con-centrations of HT29 human colon cancer cells infection (5 ×105/100 μL, 1 ×106/100 μL and 5 ×106/100 μL) and dif-ferent concentrations of cyclophosphamide ( CTX) therapy ( L-CTX and H-CTX) .Results The rates of tumor formation and tumor reduce were all 100% in the hepatic metastases of colon cancer hemispleen models.The hepatic metastasis scores in the low concentration CTX group ( L-CTX group) and high concentration CTX group ( H-CTX group) both in-creased when increased theconcentrations of HT29 human colon cancer cells injection (P<0.05).The mice with lymph node metastases or bloody ascites were significantly fewer in L-CTX group than in H -CTX group (P <0.05).The hemispleen model with infection 1 ×106/100μL HT29 human colon cancer cells showed better in model stability.Conclu-sion The hemispleen model are technically feasible and reproducible in researche on the metastatic mechanism and thera-peutic development of colorectal cancer.The feasible and stable hemispleen model could be used in screening antitumor drugs.